Loading...

The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer

Lung cancer is the most common cancer and leading cause of cancer death. While targeted therapies have redefined treatment options for non-small cell lung carcinoma (NSCLC) with genetic aberrations such as epidermal growth factor and anaplastic lymphoma kinase, many patients do not harbour these onc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ther Adv Med Oncol
Main Authors: Low, Jia Li, Walsh, Robert J., Ang, Yvonne, Chan, Gloria, Soo, Ross A.
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716180/
https://ncbi.nlm.nih.gov/pubmed/31497071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919870360
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!